Entecavir
- Product NDC
- 71921-194
- 11-digit product format
- 719210194
- Labeler code
- 71921
- Product ID
- 71921-194_b94f9be0-8dc2-0340-e053-2995a90adfc2
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Entecavir
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Florida Pharmaceutical Products, LLC
- Application
- ANDA212106
- Marketing category
- ANDA
- Marketing start
- 2021-02-26
- Marketing end
- 0000-00-00
- Substance
- ENTECAVIR
- Active strength
- 1 mg/1
- Pharmacologic classes
- Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 71921-194-33 | 71921019433 | 30 TABLET in 1 BOTTLE (71921-194-33) | 30 tablet | 2021-02-26 | 0000-00-00 | No | No | Current |